Avista Pharma Solutions, Inc. has completed a $4 million expansion of its 26,000-square foot contract testing facility in Agawam, Massachusetts.

According to company officials, “as part of an ongoing initiative, these facility and technology upgrades will enable Avista Pharma to deliver additional microbiology, sterility testing, and microbial ID service offerings.”

"We remain committed to providing best-in-class Microbiology, Analytical Chemistry and Cleanroom services," said Patrick Walsh, CEO of Avista Pharma. "This investment will complement our existing capabilities and expand our service offerings for our pharmaceutical and medical device clients."

As the result of Avista Pharma's 2016 capital investment the improved facility, , across the Connecticut River from Springfield, has 4,200 square feet of additional space, featuring a new microbiology laboratory as well as a modular cleanroom area which houses isolator technology and an ISO 6 cleanroom used for sterility testing of medical devices, pharmaceuticals, and biologics.

In addition, the laboratory support division has implemented new pass-through autoclaves and labware processing technologies that streamline workflow and complement Avista Pharma's extensive suite of microbiology services.

The facility's full range of comprehensive services will continue to include raw material and finished product release testing, ICH stability and storage, container closure integrity testing (CCIT), water system testing and validation, cleanroom monitoring and risk assessments, and microbial identification,company officials said.